Antidilutive Securities [Axis] Share capital Warrants [Member] Warrants One [Member] Option [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Distribution Agreement Placement agency agreement Investor relations agreements [Member] Related Party [Axis] Investor relations company 2 [Member] Investor relations company 3 [Member] Management Consultancy Agreement [Member] Management Consulting Company 1 [Member] Management Consulting Company 2 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Document and Entity Information: Entity Registrant Name Document Type Document Period End Date Amendment Flag Entity Central Index Key Current Fiscal Year End Date Entity Common Stock, Shares Outstanding Entity Public Float Entity Filer Category Entity Emerging Growth Company Entity Small Business Entity Shell Company Entity Ex Transition Period Entity Current Reporting Status Entity Voluntary Filers Entity Well-known Seasoned Issuer Entity Interactive Data Current Entity File Number Entity Incorporation, State or Country Code Document Fiscal Year Focus Document Fiscal Period Focus Statement of Financial Position [Abstract] ASSETS Current Assets: Cash Prepaid expenses and other receivables Inventory Total current assets Other Assets: Property and equipment, net of accumulated depreciation Intangible assets, net of accumulated amortization Total other assets Total assets LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts Payable Liability due to related parties Other Liabilities and accrued expenses Deferred revenue Total current liabilities Non-current portion of deferred revenue Total liabilities Commitments and contingencies Stockholders' equity: Common stock, $0.001 par value, 420,000,000 shares authorized; 208,016,804 and 207,655,916 shares issued and outstanding at June 30, 2019 and March 31, 2019, respectively. Additional paid in capital Accumulated deficit Accumulated other comprehensive loss Total stockholders' equity Total liabilities and stockholders' equity Common stock, par value per share Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue: Total revenues Operating Expenses: Research and development General and administrative Total operating expenses Loss from operations Interest income Net loss Other comprehensive loss: Foreign currency translation adjustment Comprehensive loss Loss per share Basic and diluted Weighted average number of common shares outstanding Statement of Cash Flows [Abstract] Cash Flows From Operating Activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and Amortization Stock Based Compensation Changes in assets and liabilities: Prepaid expenses and other receivables Inventory Accounts payable Liability due to related party Other liabilities and accrued expenses Accrued interest receivable Net cash used in operating activities Cash Flows from Investing Activities: Capitalized patent costs Purchase of property and equipment Net cash used in investing activities Cash Flows from Financing Activities: Costs incurred in relation to ATM equity financing Gross proceeds from issuance of common stock in relation to ATM financing Gross proceeds from warrant exercise Net cash provided by financing activities Net decrease in cash Effect of exchange rate changes on cash Cash at beginning of year Cash at end of year Supplemental disclosure of non-cash financing activities: Conversion of Series A preferred stock to common stock Prepayment of equity compensation Disclosure Text Block [Abstract] ORGANIZATION AND PRINCIPAL ACTIVITIES Basis of Presentation Licensing Agreement Related Party Transactions Equity [Abstract] STOCKHOLDERS' EQUITY Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] OTHER ITEMS Policy Text Block [Abstract] Basis of presentation Changes to significant accounting policies Recently adopted accounting pronouncements Table Text Block Supplement [Abstract] Schedule of Related Party Transactions Schedule of earnings (loss) per share Cash available on hand Unsecured senior credit facility description Credit facility rate Line of credit maturity term Licensing Agreement Details Narrative Non-refundable, upfront cash payment Deferred revenue Related Party Transactions [Abstract] Balance due (to)/from Pharma and NDM at beginning of period Amounts invoiced by DDL to Pharma Amount invoiced by Pharma to DDL, NM and TCL Amounts repaid by DDL to Pharma Amounts invoiced by B&W to DDL Amounts repaid by DDL to B&W Foreign exchange differences Forgiveness of payable accounted for as equity contribution Net balance due to Pharma and NDM at end of the period Basic and diluted earnings (loss) per share: Net loss attributable to common stockholders Weighted average basic and diluted shares outstanding Basic and diluted earnings (loss) per share Statement [Table] Statement [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Conversion of common stock Common stock converted into convertible Preferred Stock Conversion basis Cancellation of common stock Anti-dilutive common stock Common Stock, Shares Issued Common Stock, Shares Outstanding Number of common stock sold Proceeds from common stock sold Sale of remaining common stock Related cost Public offering price Common stock, par value Sale of warrants Proceeds from warrants Proceeds from sale of common stock and warrants Placement agent commissions Warrants exercised Warrants exercisable Warrants term Related party expenses Prepaid expenses Stock compensation expense Cash payments expenses Prepaid expenses cash Subsequent events description Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Operating Expenses Operating Income (Loss) Net Income (Loss) Attributable to Parent Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Inventories Net Cash Provided by (Used in) Operating Activities Payments to Acquire Intangible Assets Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities CostsIncurredInRelationToAtmEquityFinancing Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Deferred Revenue Related Party Transaction, Due from (to) Related Party